Overview
Join us for the Nanopore Biopharma Seminar, Bay Area, to hear the latest updates and developments from top biopharma organizations using nanopore technology. Presentations will cover single cell sequencing for biomarker discovery, direct RNA sequencing for vaccine manufacturing QC and insertion site analysis for biologics production. The team will also provide guidance on nanopore biopharma solutions and future offerings to support pre-clinical, clinical and manufacturing processes for different drug modalities including cell and gene therapies, RNA therapeutics, antibodies and more.
The agenda includes lunch, networking breaks, Q&A, product displays, and opportunities to engage with nanopore experts and colleagues.
Presentations and lunch are from 12:00 pm — 4:00 pm PT and will be followed by a networking reception from 4:00 pm — 5:00 pm. See the agenda for additional details.
Please note that this is an in-person event. There is no delegate fee to attend, but pre-registration is required. Your place will be confirmed via email from events@nanoporetech.com.
Speakers
)
scTaILoR-seq: Ultra-rich targeted single-cell long-read sequencing
William Stephenson, Principal Investigator, Genentech
William Stephenson received his B.S. in Physics from Drexel University and Ph.D from the College of ...
)
Advancing the analysis of mRNA vaccines and therapies using nanopore sequencing
Tim Mercer, Principal Investigator, BASE mRNA Facility, University of Queensland, Australia
Prof Timothy Mercer is the Director of the BASE mRNA Facility, the University Of Queensland, and is ...
)
Here or There? And Why It Matters: The Ins and Outs of Integration Site Analysis – An applications story
Colette Côté, General Manager and Chief Scientific and Portfolio Officer, PathoQuest
Colette Côté joined PathoQuest's U.S. subsidiary as General Manager and Chief Scientific and Portfol...
)
What you’re missing matters: nanopore sequencing solutions for biopharma
Bijan Zakeri, Segment Marketing Manager, Biopharma, Oxford Nanopore Technologies
Bijan Zakeri, PhD, is the Segment Marketing Manager for Biopharma at Oxford Nanopore Technologies, w...
)
Realising the potential of nanopore sequencing in Biomanufacturing QC
Veronica Fowler, Associate Director Innovation in Biomanufacturing, Oxford Nanopore Technologies
Veronica Fowler is Associate Director of Innovation in Biomanufacturing/Biopharma in the Applied Ind...
Agenda
12:00 pm — 5:00 pm PST | Agenda (subject to change) | Speaker |
|---|---|---|
12:00 — 1:00 pm | Registration/Lunch/Welcome | |
1:00 — 1:30 pm | What you're missing matters: nanopore sequencing solutions for biopharma | Bijan Zakeri, Oxford Nanopore Technologies |
1:30 — 2:00 pm | Realising the potential of nanopore sequencing in biomanufacturing QC | Veronica Fowler, Oxford Nanopore Technologies |
2:00 — 2:30 pm | scTaILoR-seq: Ultra-rich targeted single-cell long-read sequencing | William Stephenson, Genentech |
2:30 — 3:00 pm | Coffee break and product display | |
3:00 — 3:30 pm | Advancing the analysis of mRNA vaccines and therapies using nanopore sequencing | Tim Mercer, BASE mRNA Facility, University of Queensland |
3:30 — 4:00 pm | Here or There? And Why It Matters: The ins and outs of integration site analysis – an applications story | Colette Côté, PathoQuest |
4:00 — 5:00 pm | Networking reception |